{"disease":{"id":"2019-ncov","name":"2019 ncov"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05364268","title":"Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation","phase":"","overall_status":"COMPLETED","enrollment_count":514,"lead_sponsor_name":"AudibleHealth AI, Inc.","has_results":false},{"nct_id":"NCT04964115","title":"Post Acute Sequelae of COVID-19","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT04270383","title":"Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Beijing Children's Hospital","has_results":false},{"nct_id":"NCT04321928","title":"Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary","phase":"NA","overall_status":"TERMINATED","enrollment_count":449,"lead_sponsor_name":"University of Pecs","has_results":false},{"nct_id":"NCT04255017","title":"A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT04335019","title":"Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 +","phase":"","overall_status":"COMPLETED","enrollment_count":328,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04260594","title":"Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":236,"lead_sponsor_name":"Jieming QU","has_results":false},{"nct_id":"NCT06042764","title":"SA55 Injection Phase II Study in the Treatment of Mild/Moderate COVID-19 Patients","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Sinovac Life Sciences Co., Ltd.","has_results":false},{"nct_id":"NCT04268537","title":"Immunoregulatory Therapy for 2019-nCoV","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Southeast University, China","has_results":false},{"nct_id":"NCT04263402","title":"The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT04254874","title":"A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT04261426","title":"The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT04261270","title":"A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT04284046","title":"CT Scores Predict Mortality in 2019-nCoV Pneumonia","phase":"","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT07089719","title":"Bevacizumab in Post-acute Sequelae of COVID-19 : Efficacy and Safety (Pilot Study)","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":21,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04273763","title":"Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":18,"lead_sponsor_name":"Second Affiliated Hospital of Wenzhou Medical University","has_results":false},{"nct_id":"NCT04356508","title":"COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":15,"lead_sponsor_name":"Dr Gerry Gin Wai Kwok","has_results":false},{"nct_id":"NCT04334967","title":"Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care","phase":"PHASE4","overall_status":"SUSPENDED","enrollment_count":13,"lead_sponsor_name":"Providence Health & Services","has_results":false},{"nct_id":"NCT04264858","title":"Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":10,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT05027815","title":"Tregs for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Associated With COVID-19 (regARDS)","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Jeffrey Bluestone","has_results":true},{"nct_id":"NCT04261907","title":"Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection","phase":"NA","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT05077969","title":"Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Leidos Life Sciences","has_results":true},{"nct_id":"NCT05077332","title":"LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"Leidos Life Sciences","has_results":false},{"nct_id":"NCT05085574","title":"Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Leidos Life Sciences","has_results":false},{"nct_id":"NCT04272710","title":"Prognositc Factors in COVID-19 Patients Complicated With Hypertension","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Chongqing Medical University","has_results":false}],"total":25},"guidelines":[],"source":"Drug Landscape verified database"}